Tag: Daratumumab hyaluronidase-fihj FDA approval

Home / Daratumumab hyaluronidase-fihj FDA approval

Categories

The FDA has granted approval for the use of daratumumab and hyaluronidase-fihj in combination with bortezomib, lenalidomide, and dexamethasone for the treatment of multiple myeloma

July 2024: The Food and Drug Administration (FDA) has granted approval for the use of daratumumab and hyaluronidase-fihj (Darzalex Faspro, Janssen Research & Development, LLC) in conjunction with ...
daratumumab-hyaluronidase-fihj-fda-approval

Scan the code